Sponsor pipeline

Castle Creek Biosciences, LLC. clinical trial pipeline

Get alerts when Castle Creek Biosciences, LLC.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04213261 A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Active, Not Recruiting 2026-03-18
NCT06892639 Evaluation of D-Fi for the Treatment of Wounds Due to DEB Dystrophic Epidermolysis Bullosa Active, Not Recruiting 2026-03-13
Get alerts when Castle Creek Biosciences, LLC.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free